RecruitingNCT04798690
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Sponsor
Dong-A ST Co., Ltd.
Enrollment
2,500 participants
Start Date
Feb 8, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
Eligibility
Min Age: 2 Years
Inclusion Criteria2
- Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
- Children who has official height record at least 6 months prior
Exclusion Criteria1
- Children with Epiphyseal closure
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04798690
Related Trials
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
NCT049486581 location
Natural History of Noncirrhotic Portal Hypertension
NCT024177401 location
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
NCT0722185111 locations
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
NCT0582067227 locations
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
NCT0638215547 locations